Media Center Investor Relations Overview Newsroom Press Releases Company Statements InBriefs Media Center Events Stock Information Stock Quote & Chart Analyst Coverage Ownership Profile Financials SEC Filings Annual Reports Governance Governance Documents Committee Composition Investor Resources Investor FAQs Settlement Information Contact Us Investor Email Alerts Investor contact760-603-2331Email Media contact760-603-4679Email Event Details Angelman Syndrome Webcast: Results from the Phase 1/2a HALOS Study of ION582 Jul 22, 2024 8:00 AM EDT Listen to webcast Supporting Materials Angelman Syndrome Webcast Slides 3.3 MB
Angelman Syndrome Webcast: Results from the Phase 1/2a HALOS Study of ION582 Jul 22, 2024 8:00 AM EDT Listen to webcast Supporting Materials Angelman Syndrome Webcast Slides 3.3 MB
